The genotyping data showed 39 subjects with mutations of prostate cancer cases from PCR- RFLP analysis (Figure 1), including 26 positives for BRCA2 and 13 positives for HOXB13 mutations. This evidence concerns the gene BRCA2 and prostate cancer.